Table 3 Comorbid conditions
Conditions n (%) | Commercial | Medicare | ||||
|---|---|---|---|---|---|---|
Cases (n = 1159) | Controls (n = 4633) | p-value | Cases (n = 670) | Controls (n = 2680) | p-value | |
Hypertensive disease | 767 (66.2) | 2078 (44.9) | <0.0001 | 554 (82.7) | 1721 (64.2) | <0.0001 |
Ischemic heart disease | 300 (25.9) | 638 (13.8) | <0.0001 | 258 (38.5 ) | 563 (21.0) | <0.0001 |
Diseases of pulmonary circulation | 29 (2.5) | 55 (1.2) | 0.0008 | 18 (2.7) | 70 (2.6) | 0.9140 |
Other forms of heart disease | 357 (30.8) | 800 (17.3) | <0.0001 | 306 (45.7) | 713 (26.6) | <0.0001 |
Pure Hypercholesterolemia | 9 (0.8) | 24 (0.5) | 0.2957 | 6 (0.9) | 26 (1.0) | 0.8590 |
Diseases of other endocrine glands | 319 (27.5) | 754 (16.3) | <0.0001 | 285 (42.5) | 740 (27.6) | <0.0001 |
At least one of the conditions | 829 (71.5) | 2317 (50.0) | <0.0001 | 593 (88.5) | 1885 (70.3) | <0.0001 |